ArticleBMJ (Clinical research ed.)2021
Excess mortality in Wuhan city and other parts of China during the three months of the covid-19 outbreak: findings from nationwide mortality registries.
Article in BMJ (Clinical research ed.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
83 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- The collateral damage of COVID-19 to cardiovascular services: a meta-analysis.European heart journal · 2022Pooled it
- Excess all-cause deaths stratified by sex and age in Peru: a time series analysis during the COVID-19 pandemic.BMJ open · 2022Pooled it
- Pooled it
- Association of Chronic Diseases With Herpes Zoster in China: A Nationwide Population-Based Survey.Health care science · 2026Article
- Ten-year survival, clinical durability, and physiological resilience of minimally invasive versus sternotomy coronary artery bypass grafting: propensity-matched analysis.Journal of thoracic disease · 2026Article
- All-cause health-adjusted life expectancy in Jiangxi Province, China, 2000-2030: systematic estimation and analysis.Preventive medicine reports · 2026Article
- Policy stringency during the COVID-19 pandemic and healthcare services utilization in China: An interrupted time-series analysis.PLoS medicine · 2026Article
- Comparison of total intravenous anesthesia and combined inhalation and intravenous anesthesia on survival after tumor surgery: a propensity score matched cohort study.Frontiers in medicine · 2026Article
- Socio-demographic disparities in liver cancer mortality in China: a national analysis from 2015 to 2021.Frontiers in oncology · 2026Article
- Life-course restructuring of infectious mortality in China, 2004-2021: a national surveillance study.Frontiers in public health · 2026Article
- Foodborne disease outbreaks before and during the COVID-19 pandemic in Jiangsu Province, China.One health (Amsterdam, Netherlands) · 2025Article
- Changes in influenza-associated excess mortality in China between 2012-2019 and 2020-2021: a population-based statistical modelling study.Infectious diseases of poverty · 2025Article
- Urban-rural disparities in mortality due to stroke subtypes in China and its provinces, 2015-2020.Chinese medical journal · 2025Article
- Post-Pandemic Inflation and Compensatory Changes: Perception, Stress, and Difficulties by Race, Ethnicity, and Those Recovering from COVID-19 Infection.Race and social problems · 2025Article
- Post-pandemic excess mortality of COVID-19 in Hong Kong: a retrospective study.The Lancet regional health. Western Pacific · 2025Article
- Experiences, challenges, and training reflections of nurses in isolation wards during different pandemic prevention policy periods: a qualitative study.BMC nursing · 2025Article
- The impact of the COVID-19 pandemic on governmental hospitals performance indicators in city of Yazd, Iran: an interrupted time-series analysis.BMC health services research · 2025Article
- Excess mortality during COVID-19 and prediction of mortality in Bangladesh: an analysis based on death records in urban graveyards.Journal of global health · 2025Article
- Sex- and age-specific differences in excess mortality in China during the COVID-19 pandemic: a study based on official vital statistics data.Frontiers in epidemiology · 2025Article
- Direct and indirect effects of the COVID-19 pandemic on mortality: an individual-level population-scale analysis using linked electronic health records, Wales, United Kingdom, 2016 to 2022.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2024Article
23 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
objectiveTo assess excess all cause and cause specific mortality during the three months (1 January to 31 March 2020) of the coronavirus disease 2019 (covid-19) outbreak in Wuhan city and other parts of China.
designNationwide mortality registries.
setting605 urban districts and rural counties in China's nationally representative Disease Surveillance Point (DSP) system.
participantsMore than 300 million people of all ages.
main outcome measuresObserved overall and weekly mortality rates from all cause and cause specific diseases for three months (1 January to 31 March 2020) of the covid-19 outbreak compared with the predicted (or mean rates for 2015-19) in different areas to yield rate ratio.
resultsThe DSP system recorded 580 819 deaths from January to March 2020. In Wuhan DSP districts (n=3), the observed total mortality rate was 56% (rate ratio 1.56, 95% confidence interval 1.33 to 1.87) higher than the predicted rate (1147
conclusionsExcept in Wuhan, no increase in overall mortality was found during the three months of the covid-19 outbreak in other parts of China. The lower death rates from certain non-covid-19 related diseases might be attributable to the associated behaviour changes during lockdown.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.